Literature DB >> 22989109

Mycobacterium ulcerans infection: evolution in clinical management.

Candice Simpson1, Daniel P O'Brien, Anthony McDonald, Peter Callan.   

Abstract

Mycobacterium ulcerans causes significant morbidity in various endemic locations in Australia and West Africa. The commonest presentation is as a necrotic ulcer often with surrounding subcutaneous necrosis and oedema, which can cause significant morbidity, deformity and functional impairment. Traditional treatment was wide excision and debridement with grafting or flap reconstructions further adding to morbidity and with high recurrence rates. Following publication of clinical studies where antibiotics were shown to be effective, treatment has moved towards combination management with systemic antibiotics and limited surgery involving mainly debridement of the ulcers. Identification of the 'paradoxical' immune-reconstitution syndrome has also impacted upon the extent of excision required. This paper will present the evolution in clinical management of M. ulcerans cases on the Bellarine Peninsula, Victoria, Australia.
© 2012 The Authors. ANZ Journal of Surgery © 2012 Royal Australasian College of Surgeons.

Entities:  

Keywords:  Bairsdale ulcer; Buruli ulcer; Mycobacterium ulcerans; antibiotics; debridement

Mesh:

Year:  2012        PMID: 22989109     DOI: 10.1111/j.1445-2197.2012.06230.x

Source DB:  PubMed          Journal:  ANZ J Surg        ISSN: 1445-1433            Impact factor:   1.872


  4 in total

1.  Mycolactone-Dependent Depletion of Endothelial Cell Thrombomodulin Is Strongly Associated with Fibrin Deposition in Buruli Ulcer Lesions.

Authors:  Joy Ogbechi; Marie-Thérèse Ruf; Belinda S Hall; Katherine Bodman-Smith; Moritz Vogel; Hua-Lin Wu; Alexander Stainer; Charles T Esmon; Josefin Ahnström; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2015-07-16       Impact factor: 6.823

2.  The potent effect of mycolactone on lipid membranes.

Authors:  Milène Nitenberg; Anaïs Bénarouche; Ofelia Maniti; Estelle Marion; Laurent Marsollier; Julie Géan; Erick J Dufourc; Jean-François Cavalier; Stéphane Canaan; Agnès P Girard-Egrot
Journal:  PLoS Pathog       Date:  2018-01-10       Impact factor: 6.823

3.  Assessing and managing wounds of Buruli ulcer patients at the primary and secondary health care levels in Ghana.

Authors:  Naa Okaikor Addison; Stefanie Pfau; Eric Koka; Samuel Yaw Aboagye; Grace Kpeli; Gerd Pluschke; Dorothy Yeboah-Manu; Thomas Junghanss
Journal:  PLoS Negl Trop Dis       Date:  2017-02-28

4.  Aberrant stromal tissue factor localisation and mycolactone-driven vascular dysfunction, exacerbated by IL-1β, are linked to fibrin formation in Buruli ulcer lesions.

Authors:  Louise Tzung-Harn Hsieh; Scott J Dos Santos; Belinda S Hall; Joy Ogbechi; Aloysius D Loglo; Francisco Javier Salguero; Marie-Thérèse Ruf; Gerd Pluschke; Rachel E Simmonds
Journal:  PLoS Pathog       Date:  2022-01-31       Impact factor: 6.823

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.